$Catalyst Pharmaceuticals (CPRX.US)$ Director MCENANY PATRICK J sold 137.16K shares of common stock on Nov 13, 14, 2024 at an average price of $22.579 for a total value of $3.1 million.
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.
